Literature DB >> 23942801

[Enlargement plasty of the first dorsal compartment for the surgical treatment of de Quervain's tenosynovitis].

J Bering1, D Bignion, P Kurzen.   

Abstract

OBJECTIVE: Reliable reduction of pain, observance of anatomical variations, avoidance of complications. INDICATIONS: Failure of conservative treatment, clinically obvious diagnosis, positive Finkelstein test (pathognomonic). CONTRAINDICATIONS: Previous splitting of the retinaculum of the first dorsal compartment, uncertainty of diagnosis. SURGICAL TECHNIQUE: Skin incision with protection of the branches of the superficial radial nerve, exposure of the first dorsal compartment, w-shaped incision and preparation of the retinaculum lobes, exposure of all tendons, inspection of the whole compartment and possible anatomic variations. Loose adaptation of the lobes, irrigation, hemostasis, skin closing. POSTOPERATIVE MANAGEMENT: Consequent immobilization in a thumb cast for a total of 3 weeks (+ 3 weeks optional depending on load/profession). Sutures removed after 2 weeks, then the patient can start mobilization exercises (without the splint) after 3 weeks.
RESULTS: Between August 2005 and July 2007, 38 patients (40 wrists) were operated without complications. No tendon subluxation/dislocation, one wrist with persistent slightly positive Finkelstein test, in all other cases complete relief of the symptoms. All patients would elect to repeat the surgery.

Entities:  

Mesh:

Year:  2013        PMID: 23942801     DOI: 10.1007/s00064-012-0206-3

Source DB:  PubMed          Journal:  Oper Orthop Traumatol        ISSN: 0934-6694            Impact factor:   1.154


  17 in total

1.  Compartment reconstruction for De Quervain's disease.

Authors:  J W Littler; D M Freedman; M M Malerich
Journal:  J Hand Surg Br       Date:  2002-06

2.  [The Omega "Omega" pulley plasty: a new technique for the surgical management of the De Quervain's disease].

Authors:  J Bakhach; J Sentucq-Rigal; P Mouton; R Boileau; B Panconi; J-C Guimberteau
Journal:  Ann Chir Plast Esthet       Date:  2005-08-15       Impact factor: 0.660

3.  Compartmental reconstruction for de Quervain stenosing tenosynovitis.

Authors:  George El Rassi; Remy Bleton; Dawn Laporte
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  2006

4.  [Enlargement plasty of the radio-styloid tunnel in the treatment of De Quervain tenosynovitis].

Authors:  A I Kapandji
Journal:  Ann Chir Main Memb Super       Date:  1990

5.  DeQUERVAIN'S TENOSYNOVITIS DIAGNOSTIC AND OPERATIVE COMPLICATIONS.

Authors:  R J Belsole
Journal:  Orthopedics       Date:  1981-08-01       Impact factor: 1.390

6.  Anatomical variations in the first extensor compartment of the wrist. A clinical and anatomical study.

Authors:  W T Jackson; S F Viegas; T M Coon; K D Stimpson; A D Frogameni; J M Simpson
Journal:  J Bone Joint Surg Am       Date:  1986-07       Impact factor: 5.284

7.  De Quervain's disease treatment using partial resection of the extensor retinaculum: A short-term results survey.

Authors:  M A Altay; C Erturk; U E Isikan
Journal:  Orthop Traumatol Surg Res       Date:  2011-06-15       Impact factor: 2.256

8.  DE QUERVAIN'S DISEASE: STENOSING TENOVAGINITIS AT THE RADIAL STYLOID PROCESS.

Authors:  O Z YOUNGHUSBAND; J D BLACK
Journal:  Can Med Assoc J       Date:  1963-09-07       Impact factor: 8.262

9.  Symptomatic palmar tendon subluxation after surgical release for de Quervain's disease: a case report.

Authors:  G M White; A J Weiland
Journal:  J Hand Surg Am       Date:  1984-09       Impact factor: 2.230

10.  Randomised controlled trial of local corticosteroid injections for de Quervain's tenosynovitis in general practice.

Authors:  Cyriac Peters-Veluthamaningal; Jan C Winters; Klaas H Groenier; Betty Meyboom-DeJong
Journal:  BMC Musculoskelet Disord       Date:  2009-10-27       Impact factor: 2.562

View more
  1 in total

1.  [Surgical decompression of the superficial radial nerve: Wartenberg syndrome].

Authors:  C K Spies; L P Müller; J Oppermann; W F Neiss; P Hahn; F Unglaub
Journal:  Oper Orthop Traumatol       Date:  2015-10-26       Impact factor: 1.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.